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Key Messages
1. The IFN-γ +874A allele and 
RANTES -28 G allele are risk 
factors for SARS susceptibility.
2. The RANTES -28 G allele plays 
a role in the pathogenesis of 
SARS.
3. The polymorphisms of IL-10, 
TNF-α, IL-12, IP-10, Mig and 
MCP-1 are not associated with 
SARS susceptibility.
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Introduction
Severe acute respiratory syndrome (SARS) is an infectious disease caused by 
the SARS coronavirus,1 but the pathogenesis is still far from clear.2 We have 
demonstrated that genetic haplotypes associated with low-serum mannose-
binding lectin (MBL) are associated with SARS,3 and our findings have been 
replicated recently.4 Hong Kong Chinese who are homozygotes for CLEC4M 
tandem repeats have recently been reported to be less susceptible to SARS. Other 
susceptibility genes, such as OAS-1 and MxA have also been identified.
 Cytokines are known to take an important role in antiviral action. Interferon 
(IFN)-γ from T and natural killer (NK) cells is important for driving the T helper 
cell type 1 (Th1) responses. It also activates monocytes and macrophages, which in 
turn take part in antiviral responses by producing free radicals and pro-inflammatory 
cytokines like tumour necrosis factor (TNF)-α. On the other hand, interleukin (IL)-
10 counteracts the inflammatory response by inhibiting TNF-α production and 
neutrophil activation. Interleukin-12 is important for the development of the T helper 
type 1 (Th1) response in the initial phase of bacterial, parasitic, and viral infections. 
In many viral infections, IL-12 promotes viral clearance and host recovery from 
infection.
 Chemokines play an important role in cell trafficking during immune responses. 
Acute respiratory viruses commonly induce inflammatory chemokines in local tissue. 
In a previous study we confirmed that the SARS coronavirus induces upregulation 
of a number of inflammatory chemokines, ie Regulated upon Activation Normal T 
cell-Expressed and Secreted (RANTES), interferon-gamma inducible protein 10 
(IP-10) and Monocyte Chemoattractant Protein-1 (MCP-1). The upregulation of 
these chemokines, including the monokine induced by interferon gene (Mig) may 
recruit inflammatory cells and leukocytes into the tissue.
 In this study, we hypothesised that polymorphisms of the cytokine genes, 
IFN-γ, IL-10, TNF-α, IL-12, and the chemokine genes, RANTES, IP-10, Mig and 
MCP-1, might be associated with SARS. These genes were chosen for their key 
roles in antiviral action and inflammation regulation and their polymorphisms 
based on their potential regulation of gene expression.
Methods
This study was conducted from September 2005 to August 2006.
Patient populations
The study was approved by the Clinical Research Ethics Committee of the 
Institutional Review Board of the University of Hong Kong/Hospital Authority 
Hong Kong West Cluster. This study included 495 Hong Kong Chinese patients 
with SARS (211 males and 284 females, mean±SD age was 40.74±15.73 years) 
and 578 ethnically matched healthy controls from the Red Cross (343 males 
and 235 females, mean±SD age was 30.05±9.49 years). At least 95% of the 
patients were documented as having SARS-CoV antibody seroconversion and/
or detectable SARS-CoV RNA in respiratory secretions by RT-PCR. The death 
group consisted of 57 patients who died from SARS and their mean±SD age was 
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56.2±15.3 years, with 33 males and 24 females.
Genotyping
IFN-γ +874A/T, IL-10 -1082G/A, IL-10 -592A/C, IL-12B 
promoter 318/322, IL-12B intron 2 218/221, IL-12B intron 
4 268/272, IL-12B 3’UTR A/C and TNF-α -308 G/A were 
genotyped using the TaqMan system (Applied Biosystems, 
CA, USA). RANTES -28C/G and MCP-1 -2518A/G were 
genotyped using polymerase chain reaction-restriction 
fragment length polymorphism (PCR-RFLP). RANTES 
-403A/G, RANTES In1.1T/C, IP-10 nt1811A/G, IP-10 
nt2867C/A and Mig nt367A/G were genotyped using the 
MassARRAY system (Sequenom, CA, US).
Statistical analysis
A two-step analysis was used to determine the association of 
polymorphisms with SARS. The genotype frequencies and 
allele frequencies of all the genes were compared between 
SARS patients and controls using a 3x2 Chi squared test and 
a 2x2 Chi squared test respectively. Logistic regression was 
then used to calculate the odds ratios (OR) [95% confidence 
interval (CI)] and corresponding P values of different 
genotype frequencies among SARS patients and controls 
by adjusting for age and sex as co-variables. Association 
with SARS infection outcomes (death vs survival) was then 
tested by comparing the genotype frequencies and allele 
frequencies of all the genes between the death group and the 
survival group of SARS patients using a 3x2 Chi squared 
test and a 2x2 Chi squared test respectively. The genotype 
frequencies of all the single nucleotide polymorphisms 
(SNPs) were tested for Hardy-Weinberg equilibrium 
(HWE) separately in SARS patients and controls using the 
Chi squared test. The significant P value for multiple testing 
was adjusted with Bonferroni’s correction and all statistical 
analyses were performed using SAS, version 8.02 and SAS/
Genetics (SAS Institute, NC, US).
Genotype SNP No. (%) OR (95% CI)* P value*
SARS (n=476) Control (n=449)
IFN-γ +874 A/A 332 (69.8) 203 (45.2) 5.19 (2.78 - 9.68) <0.001
A/T 127 (26.7) 189 (42.1) 2.57 (1.35 - 4.88)
T/T 17 (3.6) 57 (12.7) Reference
IL-10 -1082 A/A 439 (92.2) 411 (91.5) NS†
A/G 35 (7.4) 38 (8.5)
G/G 2 (0.4) 0 (0)
IL-10 -592 A/A 244 (51.3) 209 (46.6) NS
A/C 188 (39.5) 214 (47.7)
C/C 44 (9.2) 26 (5.8)
TNF-a -308 GG 403 (84.7) 377 (83.9) NS
GA 70 (14.7) 70 (15.6)
AA 3 (0.6) 2 (0.5)
SARS (n=470) Control (n=558)
IL-12B promoter 318/322 318/318 122 (26.0) 145 (26.4) NS
318/322 252 (53.6) 238 (43.4)
322/322 96 (20.4) 166 (30.2)
IL-12B intron 2 218/221 218/218 153 (32.6) 160 (29.3) NS
218/221 234 (49.8) 251 (45.9)
221/221 83 (17.7) 135 (24.7)
IL-12B intron 4 268/272 268/268 70 (14.9) 133 (23.8) NS
268/272 222 (47.2) 237 (42.5)
272/272 147 (31.3) 150 (26.9)
Others 31 (6.6) 38 (6.81)
IL-12B 3’UTR A/A 157 (33.4) 155 (27.9) NS
A/C 235 (50.0) 294 (52.9)
C/C 78 (16.6) 107 (19.2)
Allele
IFN-γ +874 A 791 (83.1) 595 (66.3) 2.23 (1.75 - 2.83) <0.001
T 161 (16.9) 303 (33.7)
IL-10 -1082 A 913 (95.9) 860 (95.8) NS
G 39 (4.1) 38 (4.2)
IL-10 -592 A 676 (71.0) 632 (70.4) NS
C 276 (29.0) 266 (29.6)
TNF-a -308 G 876 (92.0) 824 (91.8) NS
A 76 (8.0) 74 (8.2)
IL-12B promoter 318/322 318 496 (52.8) 528 (48.1) NS
322 444 (47.2) 570 (51.9)
IL-12B intron 2 218/221 218 540 (57.5) 571 (52.3) NS
221 400 (42.6) 521 (47.7)
IL-12B intron 4 268/272 268 376 (40.0) 517 (46.4) NS
272 533 (56.7) 560 (50.3)
Others 31 (3.3) 37 (3.30)
IL-12B 3’UTR A 549 (58.4) 604 (54.3) NS
C 391 (41.6) 508 (45.7)
Table 1. Genotype frequencies and allele frequencies of cytokines in SARS patients and controls
* P value and OR (95% CI) were calculated with the use of logistic regression models, adjusted for sex and age. After correction by Bonferroni method, the 
significant P value should be less than 0.003
† NS denotes not significant
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Results
Our case-control study for cytokines genotyped the SNPs IFN-
γ +874A/T, IL-10 -1082G/A, IL-10 -592A/C, TNF-α -308G/
A, IL-12B promoter 318/322, IL-12B intron 2 218/221, IL-12B 
intron 4 268/272 and IL-12B 3’UTR A/C in Chinese patients 
with SARS and in healthy controls. All SNPs were in HWE 
(P>0.05) in SARS patients and controls using the Chi squared 
test and the genotype distributions and allele frequencies of 
these SNPs are shown in Table 1. The IFN-γ +874A allele was 
overrepresented in the SARS patients (83.1%) when compared 
with the controls (66.3%) [P<0.001]. It was also significantly 
associated with susceptibility to SARS in a dose-dependent 
manner (P<0.001), ie individuals with IFN-γ +874 AA and 
AT genotype had OR of 5.19 (95% CI, 2.78-9.68) and 2.57 
(95% CI, 1.35-4.88) of developing SARS respectively. The 
SNPs of IL-10, TNF-α, and IL-12 SNPs were chosen for their 
potential regulation of protein expression levels. Nonetheless 
we found no significant association between these SNPs and 
SARS (Table 1). We also compared the genotype and allele 
frequencies of all the polymorphisms of the SARS patient 
death and survival groups but no significant associations were 
established.
 For the study on chemokines, RANTES -28C/G, RANTES 
-403A/G, RANTES In1.1T/C, IP-10 nt1811A/G, IP-10 
nt2867C/A, Mig nt367A/G, and MCP-1 -2518 A/G were 
genotyped. Their genotype and allele frequencies are shown 
in Table 2. The RANTES -28 CG and GG genotypes were 
significantly associated with SARS susceptibility with OR 
of 3.28 (95% CI, 2.32-4.64) and 3.06 (95% CI, 1.47-6.39) 
respectively (P<0.0001) [Table 2]. The RANTES -28 G allele 
was also significantly increased in SARS patients (P<0.0001, 
OR=2.80, 95% CI, 2.11-3.71) [Table 2]. Our data did not 
show any significant association with the SNPs of IP-10, 
Mig and MCP-1 (Table 2). All genotype frequencies of the 
chemokine polymorphisms in SARS patients and controls 
were in HWE except for the RANTES -28C/G frequency in the 
controls. To confirm that there was no genotyping error that 
may have contributed to the HWE observation, direct DNA 
sequencing was performed on 20 to 30 samples for each SNP. 
No ambiguous results were obtained. We further compared 
the genotype and allele frequencies of the RANTES -28C/G 
between the SARS death and survival groups. The RANTES 
-28 G allele was associated with death from SARS in a gene-
dosage dependent manner (P=0.014), with -28 CG and GG 
individuals having a 2.12-fold (95% CI, 1.11-4.06) and 4.01-
Genotype SNP No. (%) OR (95% CI)* P value*
SARS (n=495) Control (n=578)
RANTES -403 AA 54 (10.9) 56 (9.7) NS†
AG 223 (45.0) 262 (45.3)
GG 218 (44.0) 260 (45.0)
RANTES -28 CC 316 (63.8) 491 (84.9) Reference <0.0001
CG 154 (31.1) 73 (12.6) 3.28 (2.32 - 4.64)
GG 25 (5.0) 14 (2.4) 3.06 (1.47 - 6.39)
RANTES ln1.1 CC 54 (10.9) 54 (9.3) NS
CT 217 (43.8) 257 (44.5)
TT 224 (45.3) 267 (46.2)
IP-10 nt1811 AA 1 (0.2) 0 (0) NS
AG 38 (7.7) 29 (5.0)
GG 456 (92.1) 549 (95.0)
IP-10 nt2867 AA 1 (0.2) 0 (0) NS
AC 38 (7.7) 31 (5.4)
CC 456 (92.1) 547 (94.6)
Mig nt367 AA 1 (0.2) 0 (0%) NS
AG 38 (7.7) 34 (5.9)
GG 456 (92.1) 544 (94.1)
SARS (n=478) Control (n=421)
MCP-1 -2518 AA 115 (24.1) 113 (26.8) NS
AG 225 (47.1) 213 (50.6)
GG 138 (28.9) 95 (22.6)
Allele
RANTES -403 A 331 (33.4%) 374 (32.4%) NS
G 659 (66.6%) 782 (67.7%)
RANTES -28 C 786 (79.4%) 1055 (91.3%) 2.80 (2.11 - 3.71) <0.0001
G 204 (20.6%) 101 (8.7%)
RANTES ln1.1 C 325 (32.9%) 365 (31.6%) NS
T 665 (67.2%) 791 (68.4%)
IP-10 nt1811 A 40 (4.0%) 29 (2.5%) NS
G 950 (96.0%) 1127 (97.5%)
IP-10 nt2867 A 40 (4.0%) 31 (2.7%) NS
C 950 (96.0%) 1125 (97.3%)
Mig nt367 A 40 (4.1%) 34 (2.9%) NS
G 938 (95.9%) 1122 (97.1%)
MCP-1 -2518 A 455 (47.6) 439 (52.1) NS
G 501 (52.4) 403 (47.9)
Table 2. Genotype frequencies and allele frequencies of chemokines in SARS patients and controls
* P value and OR (95% CI) were calculated with the use of logistic regression models, adjusted for sex and age. After correction by Bonferroni method, the 
significant P value should be less than 0.003
† NS denotes not significant
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RANTES -28C/G No. (%) OR (95% CI)* P value*
Death (n=57) Survival (n=438)
Genotype 0.014
CC 26 (45.6) 290 (66.2) Reference
CG 25 (43.9) 129 (29.5) 2.12 (1.11 - 4.06)
GG 6 (10.5) 19 (4.3) 4.01 (1.30 - 12.4)
Allele 0.002
C 77 (67.5) 709 (80.9)
G 37 (32.5) 167 (19.1) 2.10 (1.30 - 3.39)
Table 3. Genotype and allele frequencies of RANTES -28C/G among death and survival groups in SARS patients
* P value and OR (95% CI) were calculated with the use of logistic regression models, adjusted for sex and age
fold (95% CI, 1.30-12.4) increased risk of death from SARS 
respectively (Table 3). No association with death from SARS 
was detected for the other chemokine genes studied.
Discussion
It has been reported previously that the IFN-γ +874A 
allele is associated with infectious diseases, revealing its 
potential role in host defences against microbial infections. 
The mechanism by which the IFN-γ +874A/T allele 
influences susceptibility to SARS may depend on its role in 
the regulation of IFN-γ production. The T allele of IFN-γ 
+874A/T provides a binding site for the transcription factor 
nuclear factor-kB (NF-kB), which is able to regulate IFN-γ 
expression. It is possible that low IFN-γ production may 
impair the anti-viral response to SARS-CoV, rendering 
these individuals more susceptible to infection with this 
virus. Our observation that the IFN-γ +874A allele was 
significantly associated with SARS-CoV infection suggests 
a genetic risk factor for SARS. The role of IFN-γ in the 
antiviral response to SARS-CoV has also been supported by 
recent studies showing that IFN-γ can inhibit the replication 
of SARS-CoV in combination with IFN-b in vitro.
 RANTES is responsible for the recruitment of 
eosinophils, lymphocytes, monocytes and basophils at the 
site of inflammation and is involved in many viral infections. 
We found that the -28 G allele of RANTES was associated 
with susceptibility to and death from SARS. RANTES -
28C/G is located at the NF-κB binding site, suggesting that 
this SNP may be involved in the regulation of RANTES 
expression. Further in vitro studies have shown that the 
RANTES -28 G allele enhances NF-κB binding that leads 
to elevation of promoter activity and increases RANTES 
expression in CD8+ T cells, CD4+ T cells and monocytes/ 
macrophages. Together with our observation that the -28 G 
allele is associated with SARS, we conclude a high level 
of RANTES may predispose individuals to developing 
SARS. Too high a level of RANTES may intensify lung 
inflammation and lead to lymphopaenia, increasing the 
chance of secondary infection and hence the death rate 
among SARS patients. Therefore, we speculate that the 
RANTES -28 G allele that associates with higher levels of 
RANTES may enhance inflammation and lead to severe 
clinical outcomes in SARS. Indeed, the RANTES -28 G 
allele did show a strong association with death in Hong 
Kong Chinese patients with SARS (Table 3).
 We did not find a significant association between the 
SNPs of IL-10, TNF-α, IL-12, IP-10, Mig, and MCP-1 and 
SARS. Nevertheless, we cannot entirely exclude the roles of 
these cytokines and chemokines in susceptibility to SARS, 
because other SNPs in these genes may also be involved in 
gene expression regulation. Further studies on other SNPs 
able to alter gene expression levels are required to ascertain 
the relationship of these SNPs with SARS.
Conclusions
We demonstrated that the IFN-γ +874A allele is significantly 
associated with SARS susceptibility in a dose-dependent 
manner.5 Due to its role in regulating IFN-γ expression, 
this allele may be involved in the pathogenesis of SARS 
by altering IFN-γ production. In addition, we demonstrated 
that the RANTES -28 G allele, which correlates with 
high RANTES production, was associated with SARS 
susceptibility.6 It was also associated with adverse SARS 
outcomes, suggesting that a high RANTES level may play 
a role in the pathogenesis of SARS.6
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